Gut microbe metabolite may aid malnutrition-related gut damage

Malnutrition remains linked to nearly half of deaths among children younger than 5 years, and a substantial share of that mortality traces back to sepsis triggered when gut bacteria breach a weakened intestinal barrier.² A new study from investigators at Baylor College of Medicine and Texas Children's Hospital, published in Proceedings of the National Academy of Sciences, identifies a microbial metabolite, isovalerate, that restored barrier function in malnourished mice and in human-derived colon organoids.¹³

"One poorly understood consequence of malnutrition is intestinal barrier erosion, which allows bacteria to escape the gut and cause invasive infections including sepsis, leading causes of mortality in malnourished children," said lead and co-corresponding author Geoffrey Preidis, MD, PhD, associate professor of pediatrics-gastroenterology, hepatology and nutrition and a member of the USDA/ARS Children's Nutrition Research Center at Baylor and Texas Children's.¹

Study design and findings in mouse and organoid models of malnutrition

The investigators used a mouse model of malnutrition alongside human-derived colon organoids to probe how the gut microbiota influences barrier integrity.¹³ In specific-pathogen-free mice, a low-protein, low-fat diet thinned the colonic mucus layer, increased gut permeability, and allowed bacterial translocation into the liver and spleen—effects observed in male but not female mice, paralleling the higher sepsis and mortality risk reported in malnourished boys.¹³ When the same diet was applied to germ-free mice, barrier dysfunction did not occur, indicating that the microbiota, not malnutrition alone, drives the damage.¹

Targeted metabolomics identified branched-chain fatty acids, a metabolite class that includes isovalerate, as depleted in malnourished mice relative to healthy controls.¹³ In human-derived colonoid monolayers, isovalerate increased transepithelial electrical resistance and rearranged junction proteins in a way that strengthened the barrier.¹³ Delivering isovalerate by colonic enema, or feeding mice leucine, which gut bacteria convert into isovalerate, both improved barrier function in malnourished male mice.¹

Clinical context: malnutrition, sepsis, and the gut barrier

Undernutrition remains linked to nearly half of deaths among children under 5 worldwide, concentrated in low- and middle-income countries.² Current management of severe acute malnutrition centers on ready-to-use therapeutic foods and phased feeding protocols, none of which directly targets gut barrier repair.¹ The barrier itself depends on coordinated function of the mucus layer, epithelial junctions, and immune cells, along with microbial metabolites whose regulatory role has been incompletely characterized.¹

Microbial metabolites and the intestinal barrier: mechanism and prior evidence

Branched-chain fatty acids such as isovalerate are fermentation byproducts of dietary amino acids, generated when gut bacteria metabolize leucine and related substrates.¹ Their effects on intestinal epithelial function have been described in other model systems, including porcine ileum-derived organoids, where isovalerate similarly enhanced barrier integrity as measured by transepithelial resistance.⁴ The Baylor group's findings extend this mechanistic picture to a malnutrition-specific context and to human-derived tissue.¹³

Expert interpretation

"This is an impactful study and I was delighted that human colon organoids validated results from mouse models and provided new insight that isovalerate enhances barrier function by modulating tight junction processes," said co-corresponding author Mary K. Estes, PhD, Distinguished Service Professor and Cullen Foundation Endowed Chair of molecular virology and microbiology at Baylor.¹ Preidis noted that leucine "costs pennies per dose, does not require refrigeration and is well-tolerated by mouth," properties that could make it feasible as a low-resource adjunct therapy if the approach translates to humans.¹

Limitations and next steps

The findings derive primarily from mouse and organoid models; whether isovalerate or leucine supplementation improves barrier function or reduces sepsis risk in malnourished children has not been tested.¹ The sex-specific effect observed in mice—barrier damage in males but not females—also requires mechanistic explanation and confirmation that it generalizes to pediatric patients.¹ Researchers described the results as pointing toward a "promising new strategy," while emphasizing that clinical studies are needed before leucine or isovalerate could be considered for malnutrition management.¹

References

1. Baylor College of Medicine. A novel intervention to potentially improve the outcome of children with malnutrition. EurekAlert! Published August 13, 2026. Accessed August 17, 2026. https://www.eurekalert.org/news-releases/1140042

2. World Health Organization. Malnutrition. Fact sheet. Updated 2024. Accessed August 17, 2026. https://www.who.int/news-room/fact-sheets/detail/malnutrition

3. Lynch LE, Soni KG, Spinler JK, et al. Microbiota-derived isovalerate ameliorates sex-specific gut barrier dysfunction in malnutrition. Proc Natl Acad Sci U S A. 2026. doi:10.1073/pnas.2611392123

4. Beaumont M, Vicente CM, Plata-Calzado C, Lencina C, Jones E, Lecuelle S, Chalvon-Demersay T. The gut microbiota metabolite isovalerate enhances the epithelial barrier function in cell monolayers derived from porcine ileum organoids. Am J Physiol Gastrointest Liver Physiol. 2026. doi:10.1152/ajpgi.00193.2025